Vaccination against communicable diseases.
D001500:BCG Vaccine; D003140:Communicable Disease Control; D004168:Diphtheria Toxoid / Q000627:therapeutic use; D005060:Europe; D005380:Financing, Government; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use; D007564:Japan; D008458:Measles Vaccine / Q000627:therapeutic use; D009108:Mumps Vaccine / Q000627:therapeutic use; D010567:Pertussis Vaccine / Q000627:therapeutic use; D011054:Poliovirus Vaccine, Inactivated / Q000627:therapeutic use; D012411:Rubella Vaccine / Q000627:therapeutic use; D012900:Smallpox Vaccine / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000627:therapeutic use; D014611:Vaccination / Q000009:adverse effects; D014765:Viral Vaccines / Q000627:therapeutic use
D001500:BCG Vaccine; D004168:Diphtheria Toxoid; D007252:Influenza Vaccines; D008458:Measles Vaccine; D009108:Mumps Vaccine; D010567:Pertussis Vaccine; D011054:Poliovirus Vaccine, Inactivated; D012411:Rubella Vaccine; D012900:Smallpox Vaccine; D013745:Tetanus Toxoid; D014765:Viral Vaccines